BHVN

Biohaven Ltd.

13.87 USD

Last updated Oct 24, 01:11 UTC

Yesterday HIGH

$16.54

Yesterday LOW

$14.45

52w HIGH

$18.57

52w LOW

$7.48

EPS

-0.78

PE

-17.78

Next Earnings

Nov 5, 2026

Overview News Unusual Options Flow Government Trades Fundamentals

Biohaven Ltd. stock is up 1.43% since 30 days ago. The next earnings date is Nov 5, 2026. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 October’s closed higher than September. In the last 10 Unusual Options Trades, there were 7 CALLs, 3 PUTs.

Options Flow Last 10
Date & Time	Expiration Date	Strike Price	Trade Type	Size	Open Interest

22 Oct 13:35	15 Jan, 2027	10.00	CALL	50	1106
22 Oct 13:36	21 Jan, 2028	10.00	CALL	100	1362
22 Oct 13:45	15 Jan, 2027	17.50	CALL	800	370
22 Oct 14:03	20 Nov, 2026	15.00	PUT	353	2
22 Oct 14:04	20 Nov, 2026	15.00	PUT	230	2
22 Oct 14:40	15 Jan, 2027	17.50	CALL	679	370
23 Oct 14:39	15 Jan, 2027	21.00	CALL	353	0
23 Oct 14:39	15 Jan, 2027	21.00	CALL	317	0
23 Oct 14:58	15 Jan, 2027	21.00	CALL	670	0
23 Oct 19:59	20 Nov, 2026	14.00	PUT	296	124

Advanced Data Unlock

Benzinga Insights

Wed Aug 26, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Biohaven (NYSE:BHVN) shares increased by 16.5% to $16.75 during Wednesday's regular session. The market value of their outstanding shares is at $2.1 billion. SCYNEXIS (NASDAQ:SCYX) stock increased by 15.7%
Benzinga Newsdesk

Wed Aug 26, 2026

Biohaven shares are trading higher after the company announced that the U.S. District Court for the District of Delaware ruled in its favor in the case against Avilar Therapeutics. Biohaven announced a collaboration agreement under which SK Biopharmaceuticals will obtain an exclusive worldwide license to the company's Kv7 ion channel platform.
Avi Kapoor

Wed Aug 26, 2026

Why JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

JOYY Inc (NASDAQ: JOYY) reported Q2 earnings below estimates, but beat revenue expectations. Shares rise 3.6% in pre-market trading.
Benzinga Newsdesk

Wed Aug 26, 2026

Biohaven Licenses Kv7 Platform And Epilepsy Candidate Opakalim To SK Biopharmaceuticals In Deal Worth Up To $795M, Biohaven To Receive $400M Upfront

SK Biopharmaceuticals to provide upfront and milestone payments related to the Kv7 platform up to $795 million, along with tiered royalties to Biohaven ranging from the mid-teens to low twenties on U.S. net sales of
Benzinga Newsdesk

Tue Aug 25, 2026

Biohaven And Yale Win $4M Judgment Against Avilar And RA Capital Over Willful Misappropriation Of Yale Trade Secret

Biohaven Ltd. and/or its wholly owned subsidiaries ("Biohaven") (NYSE:BHVN) and Yale University ("Yale") today announced that the U.S. District Court for the District of Delaware has entered judgment in
Benzinga Newsdesk

Wed Aug 12, 2026

Morgan Stanley Maintains Overweight on Biohaven, Raises Price Target to $19

Morgan Stanley analyst Terence Flynn maintains Biohaven (NYSE:BHVN) with a Overweight and raises the price target from $18 to $19.
Benzinga Newsdesk

Tue Aug 11, 2026

RBC Capital Maintains Outperform on Biohaven, Raises Price Target to $23

RBC Capital analyst Leonid Timashev maintains Biohaven (NYSE:BHVN) with a Outperform and raises the price target from $22 to $23.
Benzinga Newsdesk

Mon Aug 10, 2026

Biohaven Q2 Adj. EPS $(0.78) Misses $(0.73) Estimate

Biohaven (NYSE:BHVN) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.73) by 6.85 percent. This is a 52.15 percent increase over losses of $(1.63) per share from the same
Benzinga Newsdesk

Mon Jul 27, 2026

Biohaven And Yale University Announce Federal Jury Verdict In Their Favor In Trade Secret Misappropriation And Breach Of Contract Litigation Against Avilar Therapeutics And RA Capital

The jury found that Avilar and RA Capital willfully and maliciously misappropriated a Yale trade secret relating to its "MODA" targeted protein degradation platform, and that RA Capital separately breached its
Avi Kapoor

Fri Jul 17, 2026

ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday

US stocks lower, Nasdaq falls 400 pts. ManpowerGroup shares rise after upbeat earnings. Other big gainers: PHOE, SG, TRVI, DCBO, ZNTL, GPRE, SLS, FEIM, TRV, BHVN, KOS, BJRI, MBX.